Adagio Medical Holdings, Inc.
ADGM· Nasdaq
Filed Nov 12, 2025 · 10-Q · 43 days after period end · 0001104659-25-110345
| Metric | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|
| Revenue | $0.00 | $132.00K | $41.00K |
| Net Income | -$10.12M | $3.61M | -$10.76M |
| EPS Diluted | -$0.66 | $0.02 | -$14.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adagio Medical Holdings, Inc. · CIK 2006986 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end